PKC 412 FLT3 inhibitor therapy in AML: results of a phase II trial.
作者信息
Stone R M, De Angelo J, Galinsky I, Estey E, Klimek V, Grandin W, Lebwohl D, Yap A, Cohen P, Fox E, Neuberg D, Clark J, Gilliland D G, Griffin J D
机构信息
Dana-Farber Cancer Institute, Boston, MA, USA.
出版信息
Ann Hematol. 2004;83 Suppl 1:S89-90. doi: 10.1007/s00277-004-0850-2.
PMID:15124689
Abstract
摘要
Zotero 插件